Chapter 23 Radiation Therapy in the Treatment of Hematologic Malignancies
Preferred Treatment for Early-Stage Non-Hodgkin Lymphoma
Early-Stage Diffuse Large B-Cell Lymphoma Treated With Combined Modality Therapy
Early-Stage Follicular Grade 1 and 2 Lymphoma
Use of Involved or Regional Fields
Carefully planned radiation therapy to limited fields with modest doses can significantly reduce the risk for significant damage to the marrow reserve, the risk for developing a treatment-related malignancy, and the risk for long-term toxicity to other normal tissues such as the salivary glands, lungs, heart, kidneys, and bowel.